Adoptive transfer of CD34+ cells during murine sepsis rebalances macrophage lipopolysaccharide responses

Immunology and Cell Biology

Volumn 90, Issue 10, 2012, Pages 925-934

  Brudecki, Laura ^a   Ferguson, Donald A ^a   McCall, Charles E ^b   El Gazzar, Mohamed ^a  

^a East Tennessee State University   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Endotoxin shock; Infection; Inflammation; Monocytes macrophages; Rodent; Sepsis

Indexed keywords

CD34 ANTIGEN; LIPOPOLYSACCHARIDE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CONTROLLED STUDY; IMMUNOCOMPETENCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; SEPSIS; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD34; CECUM; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MYELOID CELLS; NEUTROPHILS; PHAGOCYTOSIS; SEPSIS;

BACTERIA (MICROORGANISMS); MURINAE; MUS; RODENTIA;

EID: 84870487654     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.32     Document Type: Article

References (55)

1. Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, Siewert JR et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 1999; 178: 288-292.
2. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC et al. Sepsisinduced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-6963.
3. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG. Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 2007; 179: 623-630.
4. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251.
5. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678-681.
6. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85: 1341-1347.
7. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 2011; 6: 273-283.
8. McCall CE, El GM, Liu T, Vachharajani V, Yoza B. Epigenetics bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J Leukoc Biol 2011; 90: 439-446.
9. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8: 776-787.
10. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813-822.
11. Remick DG. Pathophysiology of sepsis. Am J Pathol 2007; 170: 1435-1444.
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
13. Ellaban E, Bolgos G, Remick D. Selective macrophage suppression during sepsis. Cell Immunol 2004; 231: 103-111.
14. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181: 1887-1892.
15. Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 1996; 6(Suppl 1): S27-S38.
16. Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 2009; 106: 6303-6308.
17. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-1754.
18. Scumpia PO, McAuliffe PF, O'Malley KA, Ungaro R, Uchida T, Matsumoto T et al. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol 2005; 175: 3282-3286.
19. Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 2007; 110: 3673-3681.
20. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
21. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31: 2068-2071.
22. Shelley O, Murphy T, Paterson H, Mannick JA, Lederer JA. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 2003; 20: 123-129.
23. Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 2011; 17: 281-292.
24. Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A et al. IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 2001; 166: 7504-7513.
25. Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005; 121: 295-306.
26. Wysocka M, Montaner LJ, Karp CL. Flt3 ligand treatment reverses endotoxin tolerancerelated immunoparalysis. J Immunol 2005; 174: 7398-7402.
27. Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204: 1463-1474.
28. Madonna GS, Vogel SN. Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J Immunol 1985; 135: 3763-3771.
29. Rodriguez S, Chora A, Goumnerov B, Mumaw C, Goebel WS, Fernandez L et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 2009; 114: 4064-4076.
30. Merlino JI, Yowler CJ, Malangoni MA. Nosocomial infections adversely affect the outcomes of patients with serious intraabdominal infections. Surg Infect (Larchmt) 2004; 5: 21-27.
31. Muenzer JT, Davis CG, Dunne BS, Unsinger J, Dunne WM, Hotchkiss RS. Pneumonia after cecal ligation and puncture: a clinically relevant ''two-hit'' model of sepsis. Shock 2006; 26: 565-570.
32. Brudecki L, Ferguson DA, Yin D, Lesage GD, McCall CE, El Gazzar M. Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis. Infect Immun 2012; 80: 602-611.
33. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH. The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins. Ann Surg 1991; 214: 141-148.
34. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001; 16: 83-96.
35. Salkowski CA, Detore G, Franks A, Falk MC, Vogel SN. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun 1998; 66: 3569-3578.
36. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112: 321S-329SS.
37. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
38. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006; 177: 1967-1974.
39. Muenzer JT, Davis CG, Chang K, Schmidt RE, Dunne WM, Coopersmith CM et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 2010; 78: 1582-1592.
40. Unsinger J, McDonough JS, Shultz LD, Ferguson TA, Hotchkiss RS. Sepsis-induced human lymphocyte apoptosis and cytokine production in ''humanized'' mice. J Leukoc Biol 2009; 86: 219-227.
41. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993; 91: 853-861.
42. Belikoff B, Hatfield S, Sitkovsky M, Remick DG. Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice. Shock 2011; 35: 382-387.
43. Belikoff BG, Hatfield S, Georgiev P, Ohta A, Lukashev D, Buras JA et al. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J Immunol 2011; 186: 2444-2453.
44. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306: 2594-2605.
45. Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 2008; 29: 617-625. viii.
46. Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged L-argininedependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602-608.
47. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81: 1162-1172.
48. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA et al. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 2010; 148: 444-452.
49. Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. Pivotal advance: tumormediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE catabolism in myeloid cells. J Leukoc Biol 2010; 88: 839-848.
50. Chen J, Ivashkiv LB. IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci USA 2010; 107: 19438-19443.
51. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) 2002; 3: 161-173.
52. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86.
53. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193-197.
54. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7: 118-130.
55. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG. Humane endpoints in shock research. Shock 2004; 21: 17-25.